Abstract
Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia (AML). Treatment of pediatric APL is based on the combination of all-trans-retinoic acid (ATRA), an anthracycline and cytosine arabinoside. Arsenic trioxide (ATO) has been studied in adults with newly diagnosed or relapsed APL with excel lent response rates both when used as a single agent or in combination with ATRA or ATRA plus chemotherapy. There is little data on combination therapy with ATRA and ATO in pediatric APL. We present a case of an adolescent male with APL who was treated using ATRA and ATO without conventional chemotherapy agents.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 133-135 |
| Number of pages | 3 |
| Journal | Pediatric Blood and Cancer |
| Volume | 51 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 2008 |
Keywords
- APL
- ATRA
- Arsenic trioxide
- Pediatric APL
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology